(1 - 22 von 26
)
C-mo Medical Solutions raises €4.1 million aiming to ...C-mo Medical Solutions
c-mo.solutions
Alexander Ehlgen, Investment Manager at Boehringer Ingelheim Venture Fund, emphasises: “We are excited about the novel C-mo technology in analysing cough ... Alexander Ehlgen, Investment Manager at Boehringer Ingelheim Venture Fund, emphasises: “We are excited about the novel C-mo technology in analysing cough ...
History of Changes for Study: NCT ClinicalTrials.gov
classic.clinicaltrials.gov
Alexander Ehlgen, MD, PhD. Study Director POINT Biomedical Corp. Locations: United States, Kansas. Midwest Cardiology Associates Overland Park, Kansas, United ... Alexander Ehlgen, MD, PhD. Study Director POINT Biomedical Corp. Locations: United States, Kansas. Midwest Cardiology Associates Overland Park, Kansas, United ...
C-mo Medical Solutions raises €4.1 million aiming to ...analytica-world.com
www.analytica-world.com
— Alexander Ehlgen, Investment Manager at Boehringer Ingelheim Venture Fund. "We're proud to be investing in C-mo Medical Solutions. This — Alexander Ehlgen, Investment Manager at Boehringer Ingelheim Venture Fund. "We're proud to be investing in C-mo Medical Solutions. This ...
C-mo Medical Solutions raises €4.1 million in seed roundeconews.pt
econews.pt
— ... Alexander Ehlgen, investment manager at Boehringer Ingelheim Venture Fund. “This round will enable the company to further develop its — ... Alexander Ehlgen, investment manager at Boehringer Ingelheim Venture Fund. “This round will enable the company to further develop its ...
sortiert nach Relevanz / Datum